
Aindro Pharmaceuticals Private Limited
Pharmaceutical company engaged in trading and manufacturing of various medical products and drugs.
Pharmaceutical company engaged in trading and manufacturing of various medical products and drugs.
Chennai, Tamil Nadu, India
+91-XXXXXXXXXX
U24231TN2001PTC047374
047374
Private Limited Indian Non-Government Company
04 Jul 2001
28 May 2019
31 Mar 2019
Unlisted
Roc Chennai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhakar Natarajan ![]() | Director | 04-Jul-2001 | Current |
Bhuvana ![]() | Director | 02-Jan-2003 | Current |
Aindro Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 791.39% increase. The company also saw a substantial improvement in profitability, with a 305% increase in profit. The company's net worth Soared by an impressive increase of 18.96%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2017, Aindro Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Sudhakar Natarajan and Bhuvana are mutual person
₹0
₹37.15 Cr
Date | Lender | Amount | Status |
---|---|---|---|
05 May 2007 | State Bank Of India | ₹27.25 Cr | Satisfied |
31 Jul 2004 | Union Bank Of India | ₹9.90 Cr | Satisfied |
Unlock and access historical data on people associated with Aindro Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aindro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aindro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Aindro Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 May 2019 as per latest MCA records.
Aindro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Chennai.
A charge registered on 05 May 2007 via Charge ID 10110774 with State Bank Of India was fully satisfied on 17 Oct 2012.
A charge with State Bank Of India of Rs. 27.25 Cr registered on 05 May 2007 with Charge ID 10110774 was modified on 19 Oct 2011.
A charge registered on 31 Jul 2004 via Charge ID 90290465 with Union Bank Of India was fully satisfied on 17 Apr 2009.
A charge with State Bank Of India amounted to Rs. 27.25 Cr with Charge ID 10110774 was registered on 05 May 2007.
Aindro Pharmaceuticals Private Limited was incorporated on 04 Jul 2001.
The authorized share capital of Aindro Pharmaceuticals Private Limited is ₹ 16.55 Cr and paid-up capital is ₹ 2.93 Cr.
Currently 2 directors are associated with Aindro Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aindro Pharmaceuticals Private Limited is Plot No.6 Park View Apartments Nagendra Nagar Velachery, India, Chennai, Tamil Nadu, 600042.
The corporate identification number (CIN) of Aindro Pharmaceuticals Private Limited is U24231TN2001PTC047374 and the company number is 047374 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2016, the revenue trend for Aindro Pharmaceuticals Private Limited has risen by 791.39%.
The financial reports for the fiscal year 2016 indicates that The net worth of Aindro Pharmaceuticals Private Limited has experienced an upsurge of 18.96%.
The most recent Balance Sheet for Aindro Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2019.
Search company & director profiles for free and gain access to critical business data.
JJ
BS
TB
NP